Advanced Search
KANG Yani, LAI Dengpan, ZHANG Xiaoli, CHEN Jian, ZHAO Xiaodong. CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 871-875. DOI: 10.3971/j.issn.1000-8578.2014.08.003
Citation: KANG Yani, LAI Dengpan, ZHANG Xiaoli, CHEN Jian, ZHAO Xiaodong. CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 871-875. DOI: 10.3971/j.issn.1000-8578.2014.08.003

CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells

More Information
  • Objective To investigate the aberrant DNA methylation status of CpG islands in SHP1 gene promoter region in gastric cancer cells. Method CpG islands in the region of -1 000 bp-1 340 bp in transcription start sites of SHP1 gene were analyzed by Cpgplot software, and the primers of methylationspecific PCR (MSP) were designed by MethPrimer software. A new bisulfite-based MSP method was applied to detect the methylation status of SHP1 gene promoter region the limited gastric cancer cells. Bisulfite-modified DNA samples were amplified by MSP primers covering the CpG islands in SHP1 gene promoter region. The MSP products were purified cloned, which was subject to Sanger sequencing. Original and bisulfite modified partial sequences were compared. CpG loci methylation status was analyzed. Results Cpgplot displayed that MSP primers were located in SHP1 gene exon1 area which was close to the transcription initiation site. CpG islands length was > 200 bp, GC content was > 50%, and Obs/Exp was > 0.60. MSP detection showed that methylation-specific primer amplification was positive, whereas the unmethylation-specific primer amplification was negative, which revealed the region was highly methylated. Conclusion CpG islands in SHP1 gene promoter region are hypermethylated in gastric cancer cells.
  • [1]
    Sandoval J, Heyn H, Moran S, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome[J]. Epigenetics,2011,6(6):692-702.
    [2]
    Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future[J].Oncogene,2002,21 (35) :5427-40.
    [3]
    Oka T, Ouchida M, Koyama M, et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas[J].Cancer Res,2002,62(22):6390-4.
    [4]
    Kumagai C, Kalman B, Middleton FA, et al. Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects[J].J Neuroimmunol,2012,246(1-2): 51-7.
    [5]
    Capello D,Gloghini A,Baldanzi G,et al.Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma[J]. Hematol Oncol,2013,31(1):22-8.
    [6]
    Khan H,Vale C, Bhagat T, et al. Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes[J]. Semin Hematol,2013,50(1):16-37.
    [7]
    Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs[J]. Bioinformatics,2002,18(11): 1427-31.
    [8]
    Bock C, Reither S, Mikeska T, et al. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing[J]. Bioinformatics, 2005,21(21):4067-8.
    [9]
    Barekati Z, Radpour R, Kohler C, et al. Specificity of methylation assays in cancer research: a guideline for designing primers and probes[J].Obstet Gynecol Int,2010,2010.
    [10]
    Braggio E, Maiolino A, Gouveia ME,et al. Methylation status of nine tumor suppressor genes in multiple myeloma[J]. Int J Hematol, 2010,91(1):87-96.
    [11]
    Wu C, Sun M, Liu L,et al.The function of the protein tyrosine phosphatase SHP-1 in cancer[J]. Gene,2003,306:1-12.
    [12]
    Minoo P, Zadeh MM, Rottapel R, et al. A novel SHP-1/Grb2- dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling[J]. Blood,2004,103(4):1398-407.
    [13]
    Chim CS, Fung TK, Cheung WC, et al. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway[J]. Blood, 20 04,103(12):4630-5.
    [14]
    Xu SB, Liu XH, Li BH, et al.DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells[J]. J Cancer Res Clin Oncol, 20 09,135(12):1791-8.
    [15]
    Ku JL, Jeon YK, Park JG. Methylation-specific PCR[J]. Methods Mol Biol,2011,791:23-32.
    [16]
    Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A,1996,93(18):9821-6.
    [17]
    Min SY, Kim HS, Jung EJ, et al. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer[J]. Anticancer Res, 2012,32(8):3169-75.
    [18]
    Ye T, Chen Y, Fang J. DNA methylation biomarkers in serum for gastric cancer screening[J]. Mini Rev Med Chem,2010,10(11):1034-8.
    [19]
    Takamaru H, Yamamoto E, Suzuki H, et al. Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer[J].Cancer Prev Res(Phila), 20 12,5(10):1203-12.
    [20]
    To KF, Leung WK, Lee TL, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer[J]. Int J Cancer, 2002,102(6):623-8.
  • Related Articles

    [1]WU Yun, WEI Feng, WANG Zhaoxia, LI Yongchao, PANG Chunyan. Relationship of Methylation Status and mRNA Expression of PTEN, RASSF1A in Peripheral Blood with Thyroid Nodule Disease[J]. Cancer Research on Prevention and Treatment, 2016, 43(7): 577-581. DOI: 10.3971/j.issn.1000-8578.2016.07.007
    [2]NI Juan, CHEN Haiyan, CAO Neng, ZHOU Tao, XUE Jinglun, WANG Xu. Effects of Folate with Different Oxidative States on Genomic DNA Methylation in Human Lymphoblast Cell Line[J]. Cancer Research on Prevention and Treatment, 2014, 41(03): 256-259. DOI: 10.3971/j.issn.1000-8578.2014.03.013
    [3]GUO Wei, GUO Yan-li, YANG Zhi-bin, KUANG Gang, QIAO Yi-ling, DONG Zhi-ming. Promoter Methylation of Transforming Growth Factor-beta Receptor Type 1 Gene and Expression of TGF-β1 in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 524-527. DOI: 10.3971/j.issn.1000-8578.2011.05.011
    [4]XIE Fei, XIANG Xi-ying, ZHANG Ji-cai, TAO Jian-shu, FENG Jing. Methylation of Retinoic Acid Receptor β2 Promoter in Sporadic Breast Cancer Tissue[J]. Cancer Research on Prevention and Treatment, 2011, 38(04): 408-410. DOI: 10.3971/j.issn.1000-8578.2011.04.011
    [5]WEI Guo-hua, YANG Chun-yu, YANG Jing, GAO Zhi-an. Effects of Hp Infection and Methylation of p16 Gene on the Pathogenesis of Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(01): 51-54. DOI: 10.3971/j.issn.1000-8578.2011.01.015
    [6]WU Jie, CHEN Xue-jun, XUE Zhan-rui, WANG Guang-chuan. Aberrant Methylation of unc5c Gene Promoter in Colorectal Cancers[J]. Cancer Research on Prevention and Treatment, 2010, 37(06): 683-686. DOI: 10.3971/j.issn.1000-8578.2010.06.020
    [7]LI Hua, LI Yong, FAN Li-qiao, ZHAO Xue-feng, SONG Zhen-chuan, ZHAO Qun, WANG Li-li, JIAO Zhi-kai, LIU Yu. Relationship between Hypermethylation of Runx3 Gene in Promoter Region and Cogenesis, Metastasis of Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 508-510. DOI: 10.3971/j.issn.1000-8578.2703
    [8]YU Zong-tao, YUAN Ya-li, ZHANG Ji-cai, GAO Qiong, WANG Yuan-yuan. Transcriptional Expression and Promoter methylation of FHIT gene in Lung Carcinoma Tissues and Cell[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 498-500. DOI: 10.3971/j.issn.1000-8578.2226
    [9]LIU Gui-zhi, WU Yi-ming, YANG Ji-yao. Transcriptional Expression and Promoter Hypermethylation of RASSF1A and p16 Gene in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(05): 319-324. DOI: 10.3971/j.issn.1000-8578.1658
    [10]LIU Fen, YU Jie-ping, DENG Quan-jun, QI Yuan-ling, YU Hong-gang. Studying the Expression of PTEN and Its CpG Island Methylation Status in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 632-634. DOI: 10.3971/j.issn.1000-8578.1326

Catalog

    Article views (982) PDF downloads (1161) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return